Adrogolide
Template:Short description Page Template:Infobox drug/styles.css has no content.
Page Module:Infobox/styles.css has no content.
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
| Clinical data | |
|---|---|
| Other names | A-93431; ABT-431; ABT431; DAS-431; DAS431 |
| Routes of administration | Parenteral (e.g., intravenous, inhalation)[1] |
| Drug class | Dopamine D1-like receptor agonist |
| ATC code | Page Template:Plainlist/styles.css has no content.
|
| Pharmacokinetic data | |
| Bioavailability | Oral: ≤4%[1] Sublingual: 10–13%[1] Inhalational: 82–107%[1] |
| Metabolism | Deacetylation[1] |
| Metabolites | A-86929[1] |
| Elimination half-life | 3–4 hours[1] |
| Identifiers | |
| |
| CAS Number | Page Template:Plainlist/styles.css has no content. |
| PubChem CID | Page Template:Plainlist/styles.css has no content. |
| PubChem SID | Page Template:Plainlist/styles.css has no content. |
| IUPHAR/BPS | Page Template:Plainlist/styles.css has no content. |
| DrugBank | Page Template:Plainlist/styles.css has no content. |
| ChemSpider | Page Template:Plainlist/styles.css has no content. |
| UNII | Page Template:Plainlist/styles.css has no content. |
| KEGG | Page Template:Plainlist/styles.css has no content. |
| ChEBI | Page Template:Plainlist/styles.css has no content. |
| ChEMBL | Page Template:Plainlist/styles.css has no content. |
| NIAID ChemDB | Page Template:Plainlist/styles.css has no content. |
| PDB ligand | Page Template:Plainlist/styles.css has no content. |
| CompTox Dashboard (EPA) | Page Template:Plainlist/styles.css has no content. |
| Chemical and physical data | |
| Formula | C22H25NO4S |
| Molar mass | 399.51 g·mol−1 |
| 3D model (JSmol) | Page Template:Plainlist/styles.css has no content. |
| |
| |
| Data page | |
| Template:Infobox drug/data page link | |
Adrogolide (INN; developmental code names A-93431, ABT-431, and DAS-431), also known as adrogolide hydrochloride (USAN) in the case of the hydrochloride salt, is a dopamine D1-like receptor agonist which was under development for the treatment of Parkinson's disease, cognition disorders, and cocaine-related disorders but was never marketed.[2][3][4][1][5]
It is a chemically stable and rapidly converted diacetate ester prodrug of the highly selective dopamine D1 and D5 receptor full agonist A-86929.[1] The effects of adrogolide and A-86929 in animals and humans have been studied.[1][5] Side effects of adrogolide in humans included injection site reactions, asthenia, headache, nausea, vomiting, postural hypotension, vasodilation, and dizziness.[1]
Adrogolide was under development by Abbott Laboratories and DrugAbuse Sciences.[2][3][4] It reached phase 2 clinical trials for Parkinson's disease prior to the discontinuation of its development in 2001.[2][3][4] The drug is said to have been the first extensively characterized dopamine D1 receptor full agonist.[1]
See also
- List of investigational Parkinson's disease drugs
- List of investigational substance-related disorder drugs
- Dihydrexidine (DAR-0100; IP-202)
References
Page Template:Reflist/styles.css has no content.
- ^ a b c d e f g h i j k l Page Module:Citation/CS1/styles.css has no content.Giardina WJ, Williams M (2001). "Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data". CNS Drug Rev. 7 (3): 305–316. doi:10.1111/j.1527-3458.2001.tb00201.x. PMC 6741696. PMID 11607045.
- ^ a b c Page Module:Citation/CS1/styles.css has no content."Adrogolide". AdisInsight. 30 January 2013. Retrieved 1 February 2026.
- ^ a b c Page Module:Citation/CS1/styles.css has no content."Delving into the Latest Updates on Adrogolide Hydrochloride with Synapse". Synapse. 15 November 2025. Retrieved 1 February 2026.
- ^ a b c Page Module:Citation/CS1/styles.css has no content."Adrogolide Drug Profile". Ozmosi. 1 January 1900. Retrieved 1 February 2026.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Unattributed (2000). "Information Update Volume 1-24, Number 8". Drugs of the Future. 25 (8): 843–888 (844–844).
ABT-431. Adrogolide Hydrochloride [...]
Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found.